Ichthyosis bullosa of SieInens (IBS) is a congenital bullous ichthyosis without erythroderIna. In contrast to bullous congenital ichthyosiforIn erythroderIna (BeIE), there is a relatively Inild involveInent of the skin and epiderInolytic hyperkeratosis (EHK) is restricted to the upper suprabasallayers of the epiderInis. TonofilaInent aggregation was observed by EM in suprabasal cells froIn affected patients in the two faInilies under study, indicative of a keratin abnorInality. Keratin 2e is a differentiation specific type II keratin expressed suprabasally in the epiderInis. Part of the K2e gene was aInplified by polYInerase chain reaction using genoInic DNA froIn affected and unaffected individuals froIn two IBS faInilies. Direct sequencing of polymerase chain reaction products revealed a point I chthyosis bullosa of Siemens (IBS) (MIM number 146800 [1] ) is a mild type of epidermolytic ichthyosis first described by Siemens in 1937 (2) as a separate disorder from bullous congenital ichthyosiform erythroderma of Brocq (BClli, MIM number 113800 [1 D. The phenotype of this disorder was further delineated more recently [3 -5) . The disease is characterised by mild changes particularly on flexures, shins, and periumbilical region. Blistering occurs in response to mild physical trauma and results in superficial erosion or "moulting" of the outer skin. Erythroderma is not present. Keratin filament aggregates are seen by electron microscopy in the granular and upper spinous layers of the epidermis.
The cytoskeleton of epithelial cells is largely composed of keratin intermediate filaments. In epidermis, the basal cells express K5 (type II) and K14 (type I) predominantly. In suprabasal cells, synthesis of these proteins is replaced by differentiation-specific keratins Kl (rype II) and Kl0 (type I) (6) . An additional type II keratin, K2e, is expressed in epidermis [7, 8) . This is a protein of molecular weight 65.8 kDa encoded by a 2.6-kb mRNA species. Another keratin of similar molecular weight (K2p) has been shown to be of a different amino ac id composition, is encoded by a different gene, and is ex- pressed specifically in hard palate (9) . Recentl y, the K2e eDNA sequence was determined [8) . K2e is most similar to Kl in structure, consistent with its suprabasal expression pattern, which is reported to appear in the third or fourth cell layers of the epidermis, continuing outwards. It is expressed in epidermis from a number of body sites [8) .
The role of keratins in maintaining the structural integrity of the epidermis has come to light in recent years with the finding that point mutations in K5 and K141ead to various forms ofepidermolysis bullosa simplex (EBS). In EBS, cytolysis occurs in the basal cell layer where KS and K14 are specifically expressed. Similarly, mutations in K1 or Kl0 lead to suprabasal cytolysis and results in bullous congenital ichthyosiform erythroderma (BClli) , also called epidermoly tic hyperkeratosis (EHK) (recently reviewed (10)) . More recently, point mutations in the palm and sole specific K9 have been shown to be responsible for epidermolytic palmoplantar keratoderma (EPPK) (11). Here we describe a mutation in K2e associated with IBS in two unrelated British families.
MATERIALS AND METHODS
Light and Electron Microscopy Biopsy sa mples of clinically affected skin from four members of family 1 and the si ngle affected member of family 2 were processed for light and electron microscopy as described previously [12) . Briefly, the samples were fixed first in half-strength Karnovsky fixative, then in 1.3% aqueous osnuum tetroxide and then dehydrated in ethanol and embedded in epoxy resin (Taab L1boratories Equipment Ltd., Aldermaston, Berkshire, UK). Semithin (1 f.lm) and ultrathin (-80 nm) sections were cut on a Reich ert OMU4 ultramicrotome (Leica UK Ltd., Milton Keynes, UK). Semithin sections were stained with methylene blue and azure II (Richardson) for li ght microscopy. Ultrathin sections were stained with 0022-202X/94/S07.00 Copyright © 1994 by The Society for Investigative Dermatology, Inc. 277 lead citrate and uranyl acetate and viewed in a lEOL 100 CX transmission electron microscope, operating at 80 kV. Ultrathin sections of normal epidermis were prepared and examined for comparative purposes.
Polymerase Chain Reaction (PCR) A l.S-kb fragment (approximately) of the K.2e gene was amplified from genomic DNA using primers K2-S (5' GCA GTG T AA GAA TGT GCA AGA TG 3', + strand) and K2-6 (5' CAG TCA CAT TGC TGC TGA GG 3' , -strand). Primers were designed from the cD NA sequence [8) using the program PRIMER version 0.5 (1 3) and, due to the high degree of conservation between K.2e and Kl, primers were checked aga inst a K 1 /K2e DN A alignment for K2e specificiry. Due to the proximiry of the helix termination sequence to the predicted position of intron VII, this intron is included in the K.2-S/K2-6 fragment. limon VII is about 1.25 kb in size. PCR was performed in 100-/11 reaction volumes with standard buffer with 1 mM MgCI2 and 10% dimethylsulfoxide and 1 U of Amplitaq polymerase (Perkin-Elmer-Cetus, CAl. After an initial incubation at 94°C for 5 min, PCR was carried out for 30 cycles consisting of 94°C for 30 seconds, 55°C for 1 min, an d 72°C for 2 min on an Omnigene Temperature Cycler (Hybaid, UK).
Cycle Sequencing PCR fragments were resolved on 1.5% low melting point agarose gels and excised bands purified usin g Gelase (Epicentre, USA). Approximately 50 fmol of purified template DNA was sequcnced by the DS-Cycle Sequencing system (BRL, Bethesda, MD) using a [32P) end-labeled internal primer, K2-7 (5' GTTGAA TGACCTGGAGGAGG 3',+ strand). Cyele sequencing was performed using the following program: 20 cycles consisti ng of 94°C for 30 seconds, 55°C for 30 seconds, 72°C for 1 mill; followed by 10 cycles consistin g of 94 ° C for 30 scconds, 72 ° C for 1 min. Sequencing ladders were resolved on standard 6% polyacrylamide denaturing gels.
Mutation Screening by Restriction Fragment Length Polymorphism (RFLP) The mutation found in both families destroys a recognition site for the restriction enzyme Mull. Due to the close proximiry of intron VII, it was necessary to sequence part of this intron to design a primer for screening purposes. This was carried out by cycle sequencing as above with primer K2-7 (above). For screening, a 163-bp fragment containing th e mutation was PCR amplified usin g primers K2-7 and K2-14 (5' TTC CCA GTG CCC ACA CCT G 3', -strand, intron VII). Primer K.2-14 contains a I-bp mismatch to remove an unwanted Mull site that would mask the mutated site in the assay. PCR was carried out in 25/11 volumes in microplates using the conditions described above except that primer K2-14 was end-labeled with [32P). The following PCR program was used: 30 cycles consistin g of 94°C for 30 seconds, 55°C for 1 min, 72°C for 1 min. After PCR, 5 /11 of 6 X Mull buffer containing 6 mM spermidine was added. Following incubation at 60°C for 10 min, samples were cooled and incubated for 4 h at 37°C with 1 U of Mull (N ew England Biolabs). An additional Mill! site in the fragment is located 6 bp 5' from the mutated site so that digests were denatured and resolved on 6% sequencing gels. Digestion of normal alleles gives rise to a 34-bp fragment. Digestion of the mutant allele gives rise to a 40-bp fragment. Affected heterozygotes produce 34-and 40-bp fragments.
RESULTS

IBS Is
Clinically Distinct from BCIE The proband in family 1 is a 10-year-old girl (Fig 1) who was born with normal skin. She has never been erythrodermic. Blisters developed within a few monthsof age, mainly localized to the h ands and legs, precipitated by phYSical trauma. From the age of 6 months, keratotic li chenification was noted over the extensor aspects of the elbows and knees, the wrists, and the periumbilical area. On the upper, outer aspects of the arms, superficial erosion of skin was seen, a phenomenon known as rna use rung or moulting phenomenon. N ails, hair, and oral mucosa were normal. There was no palmoplantar keratoderma. Other members of the family are affected in five consecutive ge nerations. The proband in family 2 has a phenotype indistinguishable from those affected in family 1. N o other family members are affected.
Outer Suprabasal Cells in IBS Contain Abnormal Tonofilaments The microscopic findings were essentially the same in all biopsy samples. Light microscopy showed hyperkeratosis with poorly compacted cornified cells; slight or moderate acanthosis and papillomatosis; and a minimal inflammatory cell infiltrate in the superficial dermis. Epidermal cells from the mid-spinous layer up to and including the gra nular layer appeared enlarged with a pale edematous or vacuolated cytoplasm. Disintegration of the epider- mis associated with cell lysis was not apparent. These alte red cells could occur focally in groups rather than diffusely throughout the upper epidermis. Keratohyalin granules were often small and indistinct. In some sections, the stratum corneum had become detached just above its normal junction with the granular layer.
Electron microscopy revealed a structurally normal basal and lowermost suprabasal layer. Bundling or clumping of the tonofilaments was evident in th e mid-spinous layer and became more m arked in the the upper spinous and lower gra nular layer (Fig 2a) .
The filament clumps tended to be dispersed more in the cell periphery than around the nucl ei; much of the cytoplasm around the cells edematous by lig ht microscopy was fil ament free and contained polyribosomes, mitochondria and, in the granular layer, lamellar granules . Keratohyalin was associated with the clumps and also occurred as small round granules associated with polyribosomes (Fig 2a) . In normal spinous or granul ar epidermal keratinocytes the tonofilam ents were often found in loose bundles (Fig 2b) but n ever formed the tight clumps as seen in IBS skin.
IBS Patients Axe Heterozygous for a K2e
Mutation A 1.5-kb fragment of the K2e gene was amplified from genomic DNA samples using primers K2-5 and K2-6. This fragment contains all of exon7 , which encodes part of the 2B domain and the h elix termination peptide of K2e, intron VlI, and a small portion of exon 8 e ncoding the V2 domain. 256 bp of this peR fragment are coding sequence and so the deduced size of intron VII is about 1.25 kb, about twice the size of the eq ui valent intron in Kl. However, the position of the intro n was determined by direct sequencing of the peR product and is compl etely conserved, in keeping with the other type II keratins [14] .lntron splice sites were found to conform to the reported consen sus sequ ences (15] .
Gel-purified peR products derived from affected and unaffected individuals from IBS families 1 and 2 were directly sequenced using an internal primer K2-7, located in exon 7 . In five unaffected individuals analyzed from families 1 and 2 and in four n ormal, unrelated individuals, the coding sequence was found to be identical to the published cD NA sequence, with no polymorphisms or silent mutations observed. However, all affected individuals an alyzed in both lBS families (five in total) were found to be h eterozygous for a G to A transition at nucleotide 1510 of the eD NA sequence (G JslO A) as shown in Fig 3a. This produces a change of glutamic acid to lysine in codon 493 (E493K) in the hi ghly conserved LLEGEE helix termination m otif and thus is likely to be highly detrimental to keratin filament asse mbly and/or functional integrity (Fig 3b) . This mutation is analogous to those reported in KS causing EBS-DM [16] and a in K 1 causing BCIE [17] thus demonstrating once again the sensitivity of this motif to pathologic mutation in keratin molecules.
The mutation produces a Mull restriction fragment length polymorphism that was used to design a PCR-based screening test. Digestion of [32P]-labeled PCR products amplified from normal individuals using primers K2-7 and K2-14 results in a 34-bp band. All affected members of both families were found to have an additional 40-bp band (Fig 4) . This test was used to exclude the mutation from 50 normal unrelated control samples indicating that this mutation is not a common polymorphism.
Members of family 2 were genotyped with a number of highly polymorphic markers (data not shown). Normal Mendelian inheritance with no evidence of non-paternity was observed; therefore, it is likely that this sporadic case represents a new mutation.
DISCUSSION
The Observed K2e Mutation May Be a Common Cause of ms Here we describe (with Kremer et al [18] ) mutations in K2e that are associated with IBS, a pathologic condition affecting the outer layers of the epidermis. The base change observed in two unrelated incidences is consistent with a methylated CpG deamination mutation of the 5-methyl-cytosine on the antisense strand at position 1510. This results in a CG to CA transition in the sense strand. Methylated CpG sequences have a higher mutation rate than other dinucleotides, taking the obvious bias for deleterious mutations into account [19] . Here, IBS fami ly 1 has affected members in five generations; however, the affected member of IBS fami ly 2 represents a new mutation causing this disease, the parents having been shown to have a normal K2e sequence. Kremer et al [18] describe two further unrelated Dutch families with identical mutations. The occurrence of the same mutation in four apparently unrelated families including one sporadic case indicates that this is likely to be a common mutation causing rBS. hyperkeratosis and shedding of the stratum corneum. There are a number of ultrastructural features that are distinct from BClE. Firstl y, frank lysis of epidermal cells is not a prominent feature. Secondly , tonofilament clumps were not seen in the lower epidermis and also tended to be distributed more peripherally in the cells. The clinically superficial erosions or "moulting" probab ly results from separation of the stratum corneum at a low level. This could be due to abnormal structure of horny cells as reported in BCIE [20] .
IBS Ultrastructural Changes
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III-3 IV -6 III-2 IV -2 V-I V -2 I-I 1-2 II-I These ultrastructural differences between IBS and BCIE are in agreement with the differences in expression between Kl/KI0 and K2e suprabasally [8] .
The observed ultrastructural changes result in the observed clinical phenotype of the disease-very superficial epidermolytic hyperkeratosis, with scaling confined .to the outermo~t layers of the skin. The disease tends to preferentially affect certam body sltesthe elbows and knees where the epidermis is subject to a lot of flexion and/or abrasion. Further work is required, using specific antibodies or i" sitll hybridization, to determine the expression of K2e at these different body sites.
The Observed IBS Mutations Cause Keratin Filament Aggregation illS falls into a category of diseases where grossly abnormal filaments are seen by EM. The other examples where tonofilament clumping is evident are EBS-DM, BCIE, and EPPK. The unifying feature of all four of these diseases is the location of mutation in the keratin protein, within the highly conserved ends of the rod domain. In EBS-WC and EBS-K, the milder EBS variants, mutations in K5 and K 14 are found in locations other than the helix initiation and termination peptides (reviewed in [10] ). There is a body of evidence that indicates that the rod end sequences are important in production of nor.mal 10-nm filame.nts -tran~fection experiments [21, 22] , transgemcs [23] , and now disease causlllg mutations in 6 keratins [10] .
The question arises as to why these motifs are so sensitive to sequence alteration. Cross-linking studies have been interpreted as suggesting that there is a lA/2B overlap involved in higher-order assembly of intermediate filaments [24J. The manner of such an interaction is as yet unknown although studies using synthetic peptides of desmin rod ends has shown that these tend to self-aggregate into filamentous structures that contain beta-sheet conformation [25] . The region where mutations produce filament aggregation is slowly being defined by the discovery of more keratin mutations. If the rod ends are really involved in overlap interactions between dimers or tetramers, these interactions would explain why mutations in these parts of the protein are severe in their effects. However, the evidence for this is largely circumstantial at present and awaits direct experimental proof. 
